Another study showed that incorporating microsatellite instability (MSI), BRAFV600E, and KRAS mutation status into the OS model through TNM staging improves the ability to precisely prognosticate in stages II and III colon cancer [22]. The gene discussed is KRAS; the disease is colonic neoplasm.